RPLP2 and hepatocellular carcinoma: And the results indicated that the high level of RPLP2 predicted unfavorable OS in various subgroups including T1 and T2, T3 and T4, N0, M0, Stage III and IV, tumor free, age ≤ 60, hepatocellular carcinoma, R0, G3 and G4 and Child–Pugh grade A (Fig. 6D–N).